Clinical trial of a new sulphonylurea in maturity-onset diabetes--HB419 (glibenclamide).
D000367:Age Factors; D002747:Chlorpropamide / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003920:Diabetes Mellitus / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D008297:Male; D044469:Racial Groups; D012737:Sex Factors; D014044:Tolbutamide / Q000627:therapeutic use
D007004:Hypoglycemic Agents; D014044:Tolbutamide; D002747:Chlorpropamide